• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海普辛抑制前列腺癌细胞的生长/侵袭。

HEPSIN inhibits cell growth/invasion in prostate cancer cells.

作者信息

Srikantan Vasantha, Valladares Michael, Rhim Johng S, Moul Judd W, Srivastava Shiv

机构信息

Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20850-4799, USA.

出版信息

Cancer Res. 2002 Dec 1;62(23):6812-6.

PMID:12460890
Abstract

Expression of HEPSIN, a type II transmembrane serine protease in prostate cancer (CaP), has been highlighted by several studies analyzing CaP-specific gene expression alterations by cDNA microarray. Evaluations of the biological functions of HEPSIN in CaP cells are warranted for better assessment of its utility as a biomarker and/or therapeutic target. In stable clones of PC-3/HEPSIN transfectants, there was a dramatic reduction in the cell growth, cell invasion, and soft agar colony formation. A higher proportion of PC-3/HEPSIN cells were in the G(2)-M phase of the cell cycle, and there was also an increase in the cell population undergoing apoptosis. Preliminary analysis of HEPSIN transfections into LNCaP and DU145 cells further revealed cell growth-inhibitory effects. These results underscore that exogenous HEPSIN expression negatively regulates cell growth in metastatic CaP cell lines. Although the cause of the biological consequence of HEPSIN overexpression in primary CaP remains to be determined, the negative cell growth-regulatory effects of HEPSIN in metastatic CaP cells reported here have unraveled possible cellular and molecular mechanisms underlying observations that link decreased/loss of HEPSIN expression with poor prognosis of CaP.

摘要

通过cDNA微阵列分析前列腺癌(CaP)特异性基因表达变化的多项研究突出了II型跨膜丝氨酸蛋白酶HEPSIN在前列腺癌中的表达。为了更好地评估其作为生物标志物和/或治疗靶点的效用,有必要对HEPSIN在CaP细胞中的生物学功能进行评估。在PC-3/HEPSIN转染子的稳定克隆中,细胞生长、细胞侵袭和软琼脂集落形成显著减少。较高比例的PC-3/HEPSIN细胞处于细胞周期的G(2)-M期,且发生凋亡的细胞群体也有所增加。将HEPSIN转染到LNCaP和DU145细胞中的初步分析进一步揭示了细胞生长抑制作用。这些结果强调,外源性HEPSIN表达对转移性CaP细胞系中的细胞生长具有负调控作用。尽管原发性CaP中HEPSIN过表达的生物学后果的原因尚待确定,但此处报道的HEPSIN在转移性CaP细胞中的负性细胞生长调节作用揭示了将HEPSIN表达降低/缺失与CaP预后不良联系起来的观察结果背后可能的细胞和分子机制。

相似文献

1
HEPSIN inhibits cell growth/invasion in prostate cancer cells.海普辛抑制前列腺癌细胞的生长/侵袭。
Cancer Res. 2002 Dec 1;62(23):6812-6.
2
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.聚乙二醇化库尼兹结构域抑制剂可抑制肝素介导的侵袭性肿瘤生长和转移。
Cancer Res. 2009 Nov 1;69(21):8395-402. doi: 10.1158/0008-5472.CAN-09-1995. Epub 2009 Oct 20.
3
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.中和海普辛蛋白酶活性的抗体不会影响细胞生长,但会抑制培养中的前列腺和卵巢肿瘤细胞的侵袭。
Cancer Res. 2006 Apr 1;66(7):3611-9. doi: 10.1158/0008-5472.CAN-05-2983.
4
Hepsin shows inhibitory effects through apoptotic pathway on ovarian cancer cell lines.肝素通过凋亡途径对卵巢癌细胞系显示出抑制作用。
Int J Oncol. 2006 Feb;28(2):393-8.
5
PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.PMEPA1是一种雄激素调节的与NEDD4结合的蛋白质,具有细胞生长抑制功能,且在前列腺癌进展过程中表达降低。
Cancer Res. 2003 Aug 1;63(15):4299-304.
6
Hepsin inhibits the cell growth of endometrial cancer.肝素抑制子宫内膜癌的细胞生长。
Int J Mol Med. 2008 Sep;22(3):389-97.
7
Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.在激光捕获显微切割的前列腺癌中,肝素酶和乳腺丝抑蛋白呈反向表达。
J Urol. 2003 Apr;169(4):1316-9. doi: 10.1097/01.ju.0000050648.40164.0d.
8
Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.一种前列腺特异性蛋白酪氨酸磷酸酶——前列腺酸性磷酸酶对LNCaP前列腺癌异种移植瘤的抑制作用
Prostate. 2003 Jun 1;55(4):247-58. doi: 10.1002/pros.10240.
9
Expression profiling reveals hepsin overexpression in prostate cancer.表达谱分析显示前列腺癌中肝素酶过表达。
Cancer Res. 2001 Aug 1;61(15):5692-6.
10
Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.评估胃蛋白酶和N-乙酰氨基葡萄糖转移酶V在前列腺癌转移中的作用。
Anticancer Res. 2008 Jul-Aug;28(4A):1993-9.

引用本文的文献

1
Thyroid hormone suppresses cell growth by regulating CDK2 and cyclin E1 expression via Hepsin.甲状腺激素通过Hepsin调节CDK2和细胞周期蛋白E1的表达来抑制细胞生长。
Am J Cancer Res. 2025 Jun 15;15(6):2595-2603. doi: 10.62347/AKVV2832. eCollection 2025.
2
Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axis.hepsin 通过 TGFβ-EGFR 轴促进乳腺癌生长信号转导。
Mol Oncol. 2024 Mar;18(3):547-561. doi: 10.1002/1878-0261.13545. Epub 2023 Nov 13.
3
The roles of proteases in prostate cancer.蛋白酶在前列腺癌中的作用。
IUBMB Life. 2023 Jun;75(6):493-513. doi: 10.1002/iub.2700. Epub 2023 Jan 4.
4
A High-Affinity Cu-Labeled Ligand for PET Imaging of Hepsin: Design, Synthesis, and Characterization.一种用于肝胰凝蛋白酶PET成像的高亲和力铜标记配体:设计、合成与表征
Pharmaceuticals (Basel). 2022 Sep 5;15(9):1109. doi: 10.3390/ph15091109.
5
Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer.辅助性 T 细胞 1 多抗原疫苗在前列腺癌小鼠模型中的抗肿瘤活性。
Sci Rep. 2022 Aug 10;12(1):13618. doi: 10.1038/s41598-022-17950-1.
6
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer.前列腺癌中赫普辛及相关信号通路的临床意义。
Biomolecules. 2022 Jan 25;12(2):203. doi: 10.3390/biom12020203.
7
Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells.过量的组织蛋白酶 proteolytic 活性限制了致癌信号,并在前列腺癌细胞中诱导内质网应激和自噬。
Cell Death Dis. 2019 Aug 9;10(8):601. doi: 10.1038/s41419-019-1830-8.
8
Molecular alterations associated with prostate cancer.与前列腺癌相关的分子改变。
Cent European J Urol. 2018;71(2):168-176. doi: 10.5173/ceju.2018.1583. Epub 2018 Mar 16.
9
TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.TMPRSS4通过诱导Slug和细胞周期蛋白D1来诱导前列腺癌细胞的侵袭和增殖。
Oncotarget. 2016 Aug 2;7(31):50315-50332. doi: 10.18632/oncotarget.10382.
10
Type II transmembrane serine proteases as potential targets for cancer therapy.II型跨膜丝氨酸蛋白酶作为癌症治疗的潜在靶点。
Biol Chem. 2016 Sep 1;397(9):815-26. doi: 10.1515/hsz-2016-0131.